Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical features of familial ovarian cancer lacking mutations in BRCA1 or BRCA2.

European journal of gynaecological oncology - 1 Jan 2004

Menkiszak J, Gronwald J, Górski B, Byrski T, Huzarski T, Jakubowska A, Foszczyńska-Kłoda M, Brzosko M, Fliciński J, Rzepka-Górska I, Narod S A, Lubiński J

Abstract excerpt

PURPOSE OF INVESTIGATION: The purpose of the present study was to identify the clinical and pathologic features of ovarian cancers in patients who have a family history of breast or ovarian cancer but who do not have a mutation in the BRCA1 or BRCA2 gene. METHODS: 303 patients with ovarian cancer were reviewed for clinical features and for cancer family histories. After the exclusion of 51 patients known to carry...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Mutation

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Poland

Source

Identifiers

PMID: 15053073

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical features of familial ovarian cancer lacking mutations in BRCA1 or BRCA2.PMID 15053073Read ↗

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.Semantic proximity Read ↗

Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

[Familial ovarian cancer].Semantic proximity Read ↗

Clinical and genetic evaluation of thirty ovarian cancer families.Semantic proximity Read ↗

Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2.Semantic proximity Read ↗

Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.Semantic proximity Read ↗

FGFR2 mutations are rare across histologic subtypes of ovarian cancer.Semantic proximity Read ↗

Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study.Semantic proximity Read ↗

Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.Semantic proximity Read ↗

Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients.Semantic proximity Read ↗

Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer.Semantic proximity Read ↗

Familial ovarian cancer and early ovarian cancer: biologic, pathologic, and clinical features.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.